Novartis has bulked up its cardiology pipeline with a $1.4 billion takeover of Tourmaline Bio and its phase 3-ready drug for atherosclerotic cardiovascular disease (ASCVD). The Swiss pharma group has ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy cooking ...

Yahoo Sports TVyahoosports.tv is here! Watch live shows and highlights 24/7. Yahoo Sports DailyJason Fitz & Caroline Fenton bring you the top sports news to start your day. Yahoo Fantasy ...